Infiltrating lymphocytes and human papillomavirus-16-associated oropharyngeal cancer

Laryngoscope

Volumn 122, Issue 1, 2012, Pages 121-127

  Wansom, Derrick ^a   Light, Emily ^c   Thomas, Dafydd ^b   Worden, Francis ^b   Prince, Mark ^a   Urba, Susan ^b   Chepeha, Douglas ^a   Kumar, Bhavna ^a   Cordell, Kitrina ^b   Eisbruch, Avraham ^c   Taylor, Jeremy ^c   Moyer, Jeffrey ^a   Bradford, Carol ^a   D'Silva, Nisha ^b,c   Carey, Thomas ^a   McHugh, Jonathan ^b   Wolf, Gregory ^a  

^a UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

cellular immunity; Human papillomavirus; oropharyngeal cancer; T cell infiltrates

Indexed keywords

CARBOPLATIN; CD4 ANTIGEN; CD68 ANTIGEN; CD8 ANTIGEN; CISPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; FLUOROURACIL; PACLITAXEL; TRANSCRIPTION FACTOR FOXP3;

ADULT; ADVANCED CANCER; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CELL INFILTRATION; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OROPHARYNX CANCER; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TISSUE MICROARRAY; TREATMENT RESPONSE; TUMOR ASSOCIATED LEUKOCYTE;

ADULT; AGED; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES;

EID: 84255204907     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.22133     Document Type: Article

References (36)

1. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010; 363: 24-35.
2. INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TRPG 02.02 phase III trial. J Clin Oncol 2010; 28: 4142-4148.
3. Fakhry C, Gillison ML,. Clinical implications of human papillomavirus in head and neck cancers. J Clin Oncol 2006; 24: 2606-2611. (Pubitemid 46622080)
4. Chung CH, Gillison ML,. Human papillomavirus in head and neck cancer. Its role in pathogenesis and clinical implications. Clin Cancer Res 2009; 15: 6758-6762.
5. Gillison ML, D'Souza G, Westra W, et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus 16-negative head and neck cancers. J Natl Cancer Inst 2008; 100: 407-420. (Pubitemid 351480511)
6. Marur S, D'Souza G, Westra WH, Forastiere AF,. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol 2010; 11: 781-789.
7. Spanos WC, Nowicki P, Lee DW, et al. Immune response during therapy with cisplatin or radiation for human papillomavirus-related head and neck cancer. Arch Otolaryngol Head Neck Surg 2009; 135: 1137-1146.
8. Whiteside TL,. Immune responses to malignancies. J Allergy Clin Immunol 2010; 125: S272-S283.
9. Worden FP, Kumar B, Lee JS, et al. Chemoselection as a strategy for organ preservation in advanced oropharyngeal cancer: response and survival positively associated with HPV-16 copy number. J Clin Oncol 2008; 26: 3138-3146.
10. Wansom D, Light E, Worden F, et al. Correlation of cellular immunity with human papillomavirus 16 status and outcome in patients with advanced oropharyngeal cancer. Arch Otolaryngol Head Neck Surg 2010; 136: 1267-1273.
11. Ogino T, Shigyo H, Ishii H, et al. HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker. Cancer Res 2006; 66: 9281-9289. (Pubitemid 44521150)
12. Kong CS, Narasimhan B, Cao H, et al. The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys 2009; 74: 553-561.
13. Yang H, Yang K, Khafagi A, et al. Sensitive detection of human papillomavirus in cervical, head/neck, and schistosomiasis-associated bladder malignancies. Proc Natl Acad Sci USA 2005; 102: 7683-7688. (Pubitemid 40741031)
14. Lee AM, Clear AJ, Calaminici M, et al. Number of CD4+ cells and location of Forkhead box protein P3-positive cells in diagnostic follicular lymphoma tissue microarrays correlates with outcome. J Clin Oncol 2006; 24: 5052-5059. (Pubitemid 46631409)
15. Pretscher D, Distel LV, Grabenbauer GG, et al. Distribution of immune cells in head and neck cancer: CD8+ T-cells and CD20+ B-cells in metastatic lymph nodes are associated with favourable outcome in patients with oro- and hypopharyngeal carcinoma. BMC Cancer 2009; 9: 292-301.
16. Wolf GT, Schmatlz S, Hudson J, et al. Alterations in T-lymphocyte subpopulations in patients with head and neck squamous carcinoma: correlations with prognosis. Arch Otolaryngol Head Neck Surg 1987; 113: 1200-1206. (Pubitemid 18035876)
17. Vu HL, Sikora AG, Fu S, Kao J,. HPV-induced oropharyngeal cancer, immune response and response to therapy. Cancer Lett 2010; 288: 149-155.
18. Van Steenwijk PJDV, Heusinkveld M, Ramwadhdoebe TH, et al. An unexpectedly large polyclonal repertoire of HPV-specific T cells is poised for action in patients with cervical cancer. Cancer Res 2010; 70: 2707-2717.
19. Anichini A, Molla A, Vegetti C, et al. Tumor-reactive CD8+ early effector T cells identified at tumor site in primary and metastatic melanoma. Cancer Res 2010; 70: 8378-8387.
20. Bos R, Sherman LA,. CD4+ T-cell help in the tumor milieu is required for recruitment and cytolytic function of CD8+ T lymphocytes. Cancer Res 2010; 70: 8368-8377.
21. Thurlow JK, Murillo CLP, Hunter KD, et al. Spectral clustering of microarray data elucidates the roles of microenvironment remodeling and immune responses in survival of head and neck squamous cell carcinoma. J Clin Oncol 2010; 28: 2881-2888.
22. Rajjoub S, Basha SR, Einhorn E, et al. Prognostic significance of tumor-infiltrating lymphocytes in oropharyngeal cancer. Ear Nose Throat J 2007; 86: 506-511. (Pubitemid 351268069)
23. Badoual C, Hans S, Rodriquez J, et al. Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers. Clin Cancer Res 2006; 12: 465-471.
24. Wilke CM, Wo K, Ahao E, Wang G, Zou W,. Prognostic significance of regulatory T cells in tumor. Int J Cancer 2010; 127: 748-758.
25. high Foxp3+ T cells secreting Interleukin-10 and transforming growth factor-Beta1 mediates suppression in the tumor microenvironment. Clin Cancer Res 2007; 13: 4345-4354. (Pubitemid 47219698)
26. highFoxp3+ T cells in the circulation of patients with squamous cell carcinoma of the head and neck. Clin Cancer Res 2007; 13: 6301-6311. (Pubitemid 350075018)
27. Chikamatsu K, Sarakura K, Whiteside TL, Furuya N,. Relationships between regulatory T cells and CD8+ effector populations in patients with squamous cell carcinoma of the head and neck. Head Neck 2007; 29: 120-127. (Pubitemid 46167778)
28. Loose D, Signore A, Bonanno E, et al. Prognostic value of CD25 expression on lymphocytes and tumor cells in squamous-cell carcinoma of the head and neck. Cancer Biother Radiopharm 2008; 23: 25-33. (Pubitemid 351304209)
29. Watanabe Y, Katou F, Ohtani H, Nakayam T, Yoshie O, Hashimoto K,. Tumor-infiltrating lymphocytes, particularly the balance between CD8+ T cells and CCR4+ regulatory T cells, affect the survival of patients with oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010; 109: 744-753.
30. Denkert C, Loibl S, Noske A, et al. Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer. J Clin Oncol 2009; 28: 105-113.
31. Badoual C, Sandoval F, Pere H, et al. Better understanding tumor-host interaction in head and neck cancer to improve the design and development of immunotherapeutic strategies. Head Neck 2010; 32: 946-958.
32. Wolf GT, Hudson JL, Peterson KA, et al. Lymphocyte subpopulations infiltrating squamous carcinomas of the head and neck: correlations with extent of tumor and prognosis. Otolaryngol Head Neck Surg 1986; 95: 142-152. (Pubitemid 16025387)
33. An T, Sood U, Pietruk T, et al. In situ quantitation of inflammatory mononuclear cells in ductal infiltrating breast carcinoma. Relation to prognostic parameters. Am J Pathol 1987; 128: 52-60. (Pubitemid 17094335)
34. Zhang L, Conejo-Garcia JR, Kasaros D, et al. Intratumor T cells, recurrence and survival in epithelial ovarian cancer. N Engl J Med 2003; 348: 203-213. (Pubitemid 36077915)
35. Galon J, Costges A, Sancez-Cabo F, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006; 313: 1960-1964. (Pubitemid 44498003)
36. Menetrier-Caux C, Gobert M, Caux C,. Differences in tumor regulatory T-cell localization and activation status impact patient outcome. Cancer Res 2009; 69: 7895-7898.